On Monday (November 6th) Eastern Time, Dr. Daniel Skovoronsky, the chief scientist of Eli Lilly (NYSE: LLC, stock price $595.19, market value $565 billion), the world's highest pharmaceutical company by market value, expressed "extreme optimism" in an interview with MarketWatch that a major breakthrough in Alzheimer's disease is imminent, Donanemab, a drug, may become the next hot topic similar to weight loss pills (GLP-1). Skovolonsky stated that according to ex ...
阅读全文